Pharmaceuticals - United Arab Emirates

  • United Arab Emirates
  • The projected revenue for the Pharmaceuticals market in 2024 is estimated to reach US$1,956.00m.
  • Among the various markets, Oncology Drugs is expected to be the largest, with a projected market volume of US$346.60m in 2024.
  • Looking ahead, the revenue is anticipated to demonstrate a Compound Annual Growth Rate (CAGR 2024-2029) of 6.16%, resulting in a market volume of US$2,638.00m by 2029.
  • When compared globally, United States is expected to generate the highest revenue, amounting to US$630.30bn in 2024.
  • The United Arab Emirates, being a significant player in the Pharmaceuticals market, is expected to contribute to this growth.
  • The United Arab Emirates is emerging as a hub for pharmaceutical research and development, attracting top global companies.

Key regions: United States, China, Germany, Japan, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Pharmaceuticals market in United Arab Emirates has been experiencing significant growth in recent years, driven by various factors such as an increasing population, growing healthcare expenditure, and rising prevalence of chronic diseases.

Customer preferences:
Customers in the UAE pharmaceuticals market are increasingly demanding high-quality and innovative drugs that are effective in treating various diseases. They are also seeking drugs that are affordable and easily accessible. With the rise of digitalization, customers are also looking for online channels to purchase pharmaceutical products.

Trends in the market:
One major trend in the UAE pharmaceuticals market is the increasing focus on research and development of new drugs. Pharmaceutical companies are investing heavily in R&D to develop innovative drugs that can effectively treat various diseases. Another trend is the growing use of technology in the pharmaceutical industry. Digitalization is transforming the way pharmaceutical products are developed, marketed, and sold. Companies are increasingly using digital platforms to reach out to customers and promote their products.

Local special circumstances:
The UAE pharmaceuticals market is highly regulated, and the government plays a significant role in regulating the industry. The Ministry of Health and Prevention is responsible for regulating the pharmaceutical industry in the country. The government has also implemented various initiatives to promote the development of the pharmaceutical industry and improve healthcare services in the country.

Underlying macroeconomic factors:
The UAE's growing population, coupled with rising healthcare expenditure, is driving the growth of the pharmaceuticals market. The prevalence of chronic diseases such as diabetes, cancer, and cardiovascular diseases is also increasing, leading to a higher demand for pharmaceutical products. The UAE government's focus on improving healthcare services and promoting the development of the pharmaceutical industry is also contributing to the growth of the market. Additionally, the country's strategic location and favorable business environment are attracting pharmaceutical companies to invest in the UAE market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)